An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Waters Corporation (NYSE: WAT) has inaugurated its latest innovation lab, Immerse™ Delaware, at the University of Delaware's STAR campus. This facility aims to tackle major challenges in the biopharmaceutical industry by fostering collaboration between students, faculty, and industry partners. The lab is a product of a multi-year partnership established in October 2021, focusing on improving biotherapeutic development and manufacturing processes.
Positive
Inauguration of Immerse™ Delaware innovation lab at University of Delaware to enhance biopharmaceutical research.
Partnership with University of Delaware to address industry challenges through collaboration.
Negative
None.
News Summary:
Waters opens its newest innovation and research laboratory at University of Delaware (UD) Science, Technology and Advanced Research (STAR) campus
Immerse™ Delaware brings together students, faculty, and Waters scientists with industry research partners to identify and address significant challenges facing the biopharmaceutical industry
Lab opening milestone is part of multi-year Waters-UD research partnership to collaborate on projects with biopharma industry stakeholders
MILFORD, Mass. & NEWARK, Del.--(BUSINESS WIRE)--
Waters Corporation (NYSE: WAT) and The University of Delaware announced the grand opening of Immerse™ Delaware, a new Waters innovation and research laboratory. As part of their multi-year research partnership announced in October 2021, the lab opening is the first step on a journey to collaborate with biopharma scientists both in industry and academia to advance industrial processes for making and characterizing biotherapeutics.
Immerse Delaware, A Waters Innovation & Research Lab at The University of Delaware (Photo: Business Wire)
Located at the University of DelawareScience, Technology and Advanced Research (STAR) campus, Immerse Delaware is a fully functional, fit-for-purpose, bioprocess laboratory enabling a dedicated focus on the entire manufacturing process from clone selection to quality control (QC) of drug substances. It will give students, faculty and industry researchers access to use and evaluate state-of-the-art analytical technologies from Waters as well as novel analytics, consumables and software that will enable the next generation of biotherapeutics.
“Our mission to address some of the biggest challenges in the development and manufacturing of biotherapeutics requires an immense amount of work, collaboration, and diversity of thought. Immerse Delaware will enable us to tap into an ecosystem of talent and expertise in biological manufacturing, coupled with Waters’ experience in analytical technologies, to advance and accelerate the delivery of high-quality medicines to patients,” said Dr. Udit Batra, President and CEO of Waters Corporation.
“As a research institution, the University of Delaware has a long history of advancing new discoveries and innovations that make our world safer, healthier and more vibrant,” said UD President Dennis Assanis. “Today, the Immerse Delaware partnership with Waters Corp. is another exciting opportunity to extend our research impact and continue building on our successes in educating the next generation of leaders in the field of biopharmaceutical manufacturing.”
Waters selected University of Delaware as a partner due to its leadership in chemical and biological manufacturing research as well its active support of and close proximity to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a collaborative effort amongst industry, academia, and regulators.
Notable attendees at the lab opening included: Dennis Assanis, PhD, President, University of Delaware; Udit Batra, PhD, President and CEO, Waters Corporation; Chai Gadde, CEO of BioTek reMEDys; Kelvin Lee, PhD, Director, NIIMBL and Gore Professor of Biomolecular Engineering; Levi Thompson, PhD, Dean, College of Engineering, University of Delaware; and Michael Flemming, President, Delaware Biosciences.
Additional Resources
Learn more about Immerse Delaware, a Waters Innovation & Research Lab
Learn more about the University of Delaware’s STAR Campus
The University of Delaware, located in Newark, Delaware, traces its beginnings to a small private academy established in 1743. Today, UD is a research-intensive, technologically advanced institution offering more than 150 academic majors across nine colleges, serving more than 23,000 undergraduate and graduate students. The University's distinguished faculty includes internationally renowned authors, scientists and artists. The Carnegie Foundation for the Advancement of Teaching has classified UD as having very high research activity—a designation accorded fewer than 3% of U.S. colleges and universities. The University’s Science, Technology and Advanced Research (STAR) Campus in Newark is a growing center for innovation, blending cutting-edge research, top-notch academics and thriving businesses in one location. Delaware has 21 varsity sports teams that compete at the Division 1 level in the Colonial Athletic Association and the Football Championship Subdivision.
Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,800 employees worldwide, Waters operates directly in more than 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.
Waters and Immerse are trademarks of Waters Corporation.
Andrea Boyle Tippet Senior Director, External Relations
University of Delaware aboyle@udel.edu
Kevin Kempskie Senior Director, Public Relations
Waters Corporation pr@waters.com
Source: Waters Corporation
FAQ
What is the purpose of the Immerse Delaware laboratory opened by Waters Corporation?
The Immerse Delaware laboratory is designed to address significant challenges in the biopharmaceutical industry through collaboration among students, faculty, and Waters scientists.
When was the partnership between Waters Corporation and the University of Delaware announced?
The multi-year research partnership was announced in October 2021.
Where is the Immerse Delaware lab located?
The Immerse Delaware lab is located at the University of Delaware's Science, Technology and Advanced Research (STAR) campus.
What type of technologies will be utilized in the Immerse Delaware lab?
The lab will use state-of-the-art analytical technologies from Waters, along with novel analytics, consumables, and software for biotherapeutics.
What significance does the opening of Immerse Delaware have for Waters Corporation?
The opening of Immerse Delaware represents a strategic step for Waters Corporation in advancing its collaboration with the biopharma industry and enhancing the development of biotherapeutics.
